These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35626196)

  • 21. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
    Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer.
    Yang L; Sun HF; Guo LQ; Cao HB
    Cancer Manag Res; 2021; 13():7841-7850. PubMed ID: 34703308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer.
    Moschini M; Zaffuto E; Karakiewicz P; Mattei A; Gandaglia G; Fossati N; Montorsi F; Briganti A; Shariat SF
    World J Urol; 2019 Jun; 37(6):1127-1135. PubMed ID: 30276543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma.
    Ye YK; Bi XC; He HC; Han ZD; Dai QS; Liang YX; Zeng GH; Qin WJ; Chen ZN; Zhong WD
    Clin Exp Med; 2010 Sep; 10(3):153-8. PubMed ID: 20069333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis.
    Guo X; Li HH; Hu J; Duan YX; Ren WG; Guo Q; Liu PH; Cui Y; Liu LF; Chen MF; Chen JB; Zu XB
    Biochem Biophys Res Commun; 2019 Nov; 519(2):246-252. PubMed ID: 31495492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.
    Liu C; Shi B; Hao C; Wang Q; Lv Q; Xing N; Shou J; Qu L; Gao Y; Qin C; Zhao J; Shou C
    Oncotarget; 2016 Jul; 7(28):43432-43441. PubMed ID: 27223068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.
    Huang J; Li C; Zhang W; Yang F; Wang R; Zhang J; Li W; Yao X
    Ann Transl Med; 2021 Sep; 9(18):1439. PubMed ID: 34733991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
    Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
    BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis.
    Mazzone E; Mistretta FA; Knipper S; Palumbo C; Tian Z; Pecoraro A; Preisser F; Gallina A; Shariat SF; Saad F; Graefen M; Montorsi F; Briganti A; Karakiewicz PI
    BJU Int; 2019 Dec; 124(6):1006-1013. PubMed ID: 31144770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of Synthetic Magnetic Resonance Imaging Applied in the Evaluation of the Tumor Grade of Bladder Cancer.
    Cai Q; Wen Z; Huang Y; Li M; Ouyang L; Ling J; Qian L; Guo Y; Wang H
    J Magn Reson Imaging; 2021 Dec; 54(6):1989-1997. PubMed ID: 34080268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
    McNeil BK; Sorbellini M; Grubb RL; Apolo A; Cecchi F; Athauda G; Cohen B; Giubellino A; Simpson H; Agarwal PK; Coleman J; Getzenberg RH; Netto GJ; Shih J; Linehan WM; Pinto PA; Bottaro DP
    J Transl Med; 2014 Oct; 12():199. PubMed ID: 25335552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder.
    Sampogna G; Maltagliati M; Galfano A; Bocciardi A; Rocco B; Micali S; Montanari E; Spinelli M
    Spinal Cord Ser Cases; 2020 Jul; 6(1):61. PubMed ID: 32647234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
    Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
    Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders.
    Cai S; Feng Y; Ye J; Deng Y; Cai Z; Zhu X; Liu R; Zhang Y; Zou Z; Tang Z; Han Z; Hon CT; Zhong W; He H
    Transl Androl Urol; 2021 Sep; 10(9):3579-3590. PubMed ID: 34733654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.
    Morales EE; Grill S; Svatek RS; Kaushik D; Thompson IM; Ankerst DP; Liss MA
    Eur Urol; 2016 Mar; 69(3):407-10. PubMed ID: 26320383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse.
    Pillalamarri N; Shalom D; Sanidad S; Akerman M; Lind L; Winkler H
    Int Urogynecol J; 2015 Jan; 26(1):85-90. PubMed ID: 24980137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupation and Bladder Cancer Phenotype: Identification of Workplace Patterns That Increase the Risk of Advanced Disease Beyond Overall Incidence.
    Noon AP; Martinsen JI; Catto JWF; Pukkala E
    Eur Urol Focus; 2018 Sep; 4(5):725-730. PubMed ID: 28753772
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.